Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
Emma Groarke, Associate Research Physician at the National Institutes of Health, shared on LinkedIn:
”Super excited to see our review on VEXAS syndrome now out in The Lancet Group.
Since VEXAS was first discovered at The National Institutes of Health five years ago, we have developed a large multidisciplinary clinical program encompassing National Heart, Lung, and Blood Institute and National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) seeing patients in our combined hematology and rheumatology clinic and developing therapeutic strategies.
While progress has been made, there is much left learn and discover for our patients.
Alice Fike, Peter Grayson, Bhavisha Patel, Kaitlin Quinn, Benjamin Turturice”
Read the full article here.
Article: VEXAS syndrome: a comprehensive review of pathogenesis, clinical spectrum, and therapeutic strategies
Authors: Emma Groarke, Benjamin Turturice, Bhavisha A. Patel, Kaitlin A. Quinn, Alice Fike, Peter C. Grayso
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 23, 2026, 16:21Azin Alizadehasl: Introducing the Second Edition of a New Book on Echocardiography and Cardiac MRI
-
Feb 23, 2026, 16:16Kalyan Roy: When and Why Blood Irradiation Matters in Transfusion Medicine
-
Feb 23, 2026, 15:59Ney Carter Borges: Antithrombotic Therapy in 2025 – A Precision-Based Pharmacologic Update
-
Feb 23, 2026, 15:54Alan Nurden: From Early Discoveries to New Therapeutic Advances in von Willebrand Disease
-
Feb 23, 2026, 15:52Gevorg Tamamyan: Albania’s Vision for the Future of Pediatric Oncology
-
Feb 23, 2026, 15:36Simon Senanu: The Peripheral Blood Smear as an Essential Diagnostic Tool in Modern Medicine
-
Feb 23, 2026, 15:32Cheng-Hock Toh: The Paradox of Hematology
-
Feb 23, 2026, 15:20Rabab Al Dawood: Moderating the Coagulation and Hemostasis Session at the ISLH 1st Joint Conference
-
Feb 23, 2026, 15:16Amira Khater: Key Updates on Pulmonary Embolism Management from AHA and ACC Guidelines